Do drug metabolism enzymes vary by racial and ethnic groups? Dr. Brandy Gunsolus and Dr. Dana Powell Baker discuss the history of race correction in drug metabolism.

How can clinical practice be an accurate reflection of racial and ethnic differences? Dr. Brandy Gunsolus and Dr. Dana Powell Baker share their perspectives.

How have laboratory medicine practices used race-based corrections? Dr. Brandy Gunsolus discusses race-based corrections, patient impacts, and where things stand today.

What are some ways that laboratory medicine practiced might be corrected more quickly? Dr. Brandy Gunsolus and Dr. Dana Powell Baker share their perspectives.

How does systemic mastocytosis increase the risk of life-threatening anaphylactic shock? And how can patients protect themselves? Medical laboratory scientist Dr. Brandy Gunsolus explains.

How can patients truly be prepared for the next outbreak? Laboratory scientist Dr. Rodney Rohde takes us on a compelling journey through the landscape of emerging infectious diseases.

What are some solutions toward solving diabetic inequities? Dr. Kyle Riding shares his recommendations for policymakers and healthcare organizations to improve care.

Does gestational diabetes increase risk of diabetes or diabetic complications? Dr. Kyle Riding explains the risk factor and provides proactive advice.

Urine samples play a crucial role in assessing the health of your kidneys and detecting conditions like diabetes, urinary tract infections, and kidney disease. But how accurate are these tests, and what if there was a way to make them even better?

Does rural medicine present its own diagnostic testing issues or its own set of inequities? Do individuals in rural or remote areas come at a disadvantage when accessing these necessary diagnostic tests? Hear from respected medical laboratory scientist Dr. Brandy Gunsolus.

The journey back to health can be challenging for many individuals recovering from COVID-19. But researchers may have uncovered vital clues that may pave the way for a much-needed diagnostic test and potential treatments for Long COVID.

Diabetes patients should receive periodic microalbumin testing, but how often should they get tested? Dr. Kyle Riding explains microalbumin testing and shares proactive advice.

Respected medical laboratory scientists Dr. Brandy Gunsolus and Dr. Dana Baker discuss the complex interplay between lab values and ethnicity.

Preeclampsia affects a significant number of pregnant women worldwide. And while it can be alarming, a recent development offers new hope for early detection and better management.

How can diagnostic testing issues for transgender patients be overcome? Dr. Brandy Gunsolus shares where research on reference ranges stands and hopes for future solutions.

Lupus nephritis is a complex condition, but what happens exactly? Medical laboratory scientist Dr. Kyle Riding explains the condition and lupus nephritis management.

Unlike other types of kidney cancer, RMC poses a significant challenge with less than 5 percent of patients surviving beyond three years using standard treatments. However, recent research offers new hope.

Is there research or data focused on health testing disparities impacting the LGBTQIA community? How can LGBTQIA communities best advocate for themselves?

What are the key differences between type 1 diabetes versus type 2 diabetes? Dr. Kyle Riding explains.

Are health disparities sometimes worsened unintentionally by laboratory medicine? Dr. Marilyn Bibbs Freeman discusses cost issues and systemic issues with laboratory medicine and the U.S. healthcare system.